Vir Biotechnology Statistics
NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.39-0.48 (-5.41%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vir Biotechnology by the numbers
Vir Biotechnology has a market capitalization of $1.56 billion based on 186.27M shares outstanding. With trailing EPS of $-1.18, Vir Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.4% below its 50-day average and 14.4% below its 200-day average.
Average daily trading volume is 2.45M shares, or about $20.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VIR valuation vs. peer median
| Metric | VIR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.56B | $1.50B | +4% |
| Avg. volume | 2.45M | 594.01K | +313% |
Peer median across 8 companies: RXRX, ALVO, WWB, MESO, MAZE, LYCA, IMCR, REPL.
Valuation
- Market cap
- $1.56B
- Price / sales (latest FY)
- 22.80
- EPS (TTM)
- $-1.18
- Shares outstanding
- 186.27M
Price and trading
- Previous close
- 8.87
- Open
- 8.81
- Day range
- 8.34 – 8.92
- 52-week range
- 5.45 – 14.38
- 52-week change
- +47.71%
- Beta
- —
- Volume
- 3.09M
- Average volume
- 2.45M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.56B
- Forward Pe
- -3.51
- Eps
- -1.18
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.38
- Week52 Low
- 5.45
- Avg Volume
- 2.45M
- Shares Outstanding
- 186.27M
- Ma50
- 10.96
- Ma200
- 9.80
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -41.66%
- Pct From52w Low
- 53.94%